COMMUNIQUÉS West-GlobeNewswire

Canada House Announces Further Details of Vegreville Acquisition and Second Tranche of Funding from Alumina Partners

04/01/2019 - 14:00

TORONTO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Last month, Canada House Wellness Group Inc. (“Canada House” or the “Company”) was pleased to announce the acquisition through its wholly owned subsidiary Abba Medix Corp., of [...]

Result of General Meeting

04/01/2019 - 13:30

Summit Therapeutics plc (“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic [...]

Idera Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 13:30

EXTON, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present at the 37 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 [...]

Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 13:30

DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that M. Michelle Berrey, M.D [...]

Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets

04/01/2019 - 13:30

Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates for multiple sclerosis, spinal muscular atrophy and other neurological diseases to [...]

Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions

04/01/2019 - 13:30

C4T’s targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen’s broader research and development efforts across multiple modalities CAMBRIDGE [...]

Eckert & Ziegler BEBIG: Meeting Minutes Extraordinary General Meeting

04/01/2019 - 10:29

Seneffe, January 4, 2019. The Minutes and all relevant documents regarding the Extraordinary General Assembly 2018 can be downloaded on the website: http://www.bebig.com/home/investors/shareholder_information/ About [...]

Eckert & Ziegler BEBIG: Procès verbal de l'assemblée générale extraordinaire des actionnaires

04/01/2019 - 10:29

Seneffe, le 4 janvier 2019. Le procès verbal ainsi que tous les documents relatifs à l'assemblé générale extraordinaire 2018 peuvent être téléchargés sur le site internet: http://www.bebig.com/home/investors/ [...]

Zealand Pharma completes equity investment in strategic partner Beta Bionics

04/01/2019 - 10:06

Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta Bionics’ series B financing [...]

Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients

04/01/2019 - 08:01

Orion Corporation Press release 4 January 2019 at 9.00 a.m. Orion Corporation and Fifth Corner Inc join forces to research solutions for improving the quality of life of prostate cancer patients Orion Corporation, a [...]

ASLAN Pharmaceuticals Announces IND Submission for ASLAN003 to U.S. FDA and Conclusion of 30-Day Review Period

04/01/2019 - 08:00

- ASLAN003 is an orally active, potent inhibitor of DHODH that has the potential to be first-in-class in AML - Positive interim Phase 2a data for ASLAN003 in AML was presented at the 2018 ASH Annual Meeting SINGAPORE, [...]

VYZULTA Approved in Canada by Nicox's Partner

04/01/2019 - 07:31

Press Release VYZULTA Approved in Canada by Nicox's Partner ............................................... January 4, 2019 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX [...]

VYZULTA approuvé au Canada par le partenaire licencié de Nicox

04/01/2019 - 07:31

Communiqué de presse VYZULTA TM approuvé au Canada par le partenaire licencié de Nicox ................................................. 4 janvier 2019 - diffusion à 7h30 Sophia Antipolis, France Nicox SA (Euronext [...]

Basilea presenting at the 37th Annual J. P. Morgan Healthcare Conference - delivering on its strategy

04/01/2019 - 07:16

Basel, Switzerland, January 04, 2019 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that David Veitch, Chief Executive Officer of Basilea, will present at the 37 th Annual J. P. Morgan Healthcare Conference on [...]

Kiadis Pharma expands presence in the United States

04/01/2019 - 07:01

Kiadis Pharma expands presence in the United States Scott Holmes commences position as chief financial officer Amy Sullivan appointed senior vice president, corporate affairs Both are based in Boston, Massachusetts [...]

WishBone Medical’s response to OrthoPediatrics press release

04/01/2019 - 01:26

WARSAW, Ind., Jan. 03, 2019 (GLOBE NEWSWIRE) -- The following is a statement by WishBone Medical: “Both the motion and OrthoPediatrics’ case as a whole are without merit and OP knows it. OP is merely trying to use this [...]

Gritstone Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference

04/01/2019 - 00:16

EMERYVILLE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]

Avivagen Inc. Announces Change of Auditor

03/01/2019 - 23:00

OTTAWA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) announces the appointment of UHY McGovern Hurley LLP as auditors. UHY McGovern Hurley LLP has been appointed to carry out the audit of [...]

MPX Announces Acquisition of Remaining Interests in Massachusetts Companies

03/01/2019 - 23:00

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“MPX”) (CSE: MPX; OTC: MPXEF) announced that on December 28, 2018, it had agreed to acquire certain minority interests in two Massachusetts [...]